Intravenous 5-fluoro-2′-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors
Titel:
Intravenous 5-fluoro-2′-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors
Auteur:
Coyne, Geraldine O.’Sullivan Wang, Lihua Zlott, Jennifer Juwara, Lamin Covey, Joseph M. Beumer, Jan H. Cristea, Mihaela C. Newman, Edward M. Koehler, Stephen Nieva, Jorge J. Garcia, Agustin A. Gandara, David R. Miller, Brandon Khin, Sonny Miller, Sarah B. Steinberg, Seth M. Rubinstein, Larry Parchment, Ralph E. Kinders, Robert J. Piekarz, Richard L. Kummar, Shivaani Chen, Alice P. Doroshow, James H.